Glenn Alfons Friedrich
Geschäftsführer bei Kymab Ltd.
Profil
Glenn Alfons Friedrich is the founder of Ceros Pharmaceuticals, Inc. (founded in 2000).
He is currently the Director at Wrnch, Inc. and the Chief Operating Officer at Kymab Ltd.
(since 2014).
Previously, he worked as a Senior Research Director at BCM Technologies, Inc. (2005-2007), a Senior Scientist at Lexicon Pharmaceuticals, Inc., and a Principal at Progression Therapeutics, Inc. Dr. Friedrich completed his undergraduate degree at the University of Alberta and holds a doctorate from Baylor College of Medicine.
Aktive Positionen von Glenn Alfons Friedrich
| Unternehmen | Position | Beginn |
|---|---|---|
Kymab Ltd.
 Kymab Ltd. Pharmaceuticals: MajorHealth Technology Kymab Ltd. discovers and develops human monoclonal antibody drugs. It is using mouse embryonic stem cell technology to develop its Kymouse platform that focuses on encompassing the diversity of the B lymphocyte component of the human immune system, and has the potential for expansion of diversity beyond the normal human immune response. Kymab was founded by Allan Bradley in 2009 and is headquartered in Cambridge, the United Kingdom. | Geschäftsführer | - |
Wrnch, Inc.
 Wrnch, Inc. Packaged SoftwareTechnology Services Wrnch, Inc. operates as computer vision Software Company. It is an automated human motion capture system that takes 2D video and outputs 3D skeletonal animation data. The company was founded by Paul Kruszewski and is headquartered in Montreal, Canada. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Glenn Alfons Friedrich
| Unternehmen | Position | Ende |
|---|---|---|
BCM Technologies, Inc.
 BCM Technologies, Inc. Investment ManagersFinance BCM Technologies Inc (BCM Technologies) is a venture capital subsidiary of Baylor University founded in 1983. The firm is headquartered in Houston, Texas. | Direktor der Forschung - Eigenkapital | 01.01.2007 |
| LEXICON PHARMACEUTICALS, INC. | Technik-/Wissenschafts-/F&E-Leiter | - |
Progression Therapeutics, Inc.
 Progression Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Progression Therapeutics, Inc. develops prognostic tests and therapies for the treatment of cancer. Its products are used in the treatment of primary and metastatic cancer. The firm develops a tumor suppressor gene product that has demonstrated potent anti-tumor activity both in vitro and in vivo. The company was founded on December 27, 2001 and is headquartered in Houston, TX. | Direktor/Vorstandsmitglied | - |
Ceros Pharmaceuticals, Inc.
 Ceros Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ceros Pharmaceuticals, Inc. develops compounds to treat osteoporosis. The company is based in Houston, TX. The company was founded by Glenn Alfons Friedrich. Ceros Pharmaceuticals was acquired by Auxeris Therapeutics, Inc. on January 14, 2004. | Gründer | - |
Ausbildung von Glenn Alfons Friedrich
| University of Alberta | Undergraduate Degree |
| Baylor College of Medicine | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| LEXICON PHARMACEUTICALS, INC. | Health Technology |
| Private Unternehmen | 5 |
|---|---|
BCM Technologies, Inc.
BCM Technologies, Inc. Investment ManagersFinance BCM Technologies Inc (BCM Technologies) is a venture capital subsidiary of Baylor University founded in 1983. The firm is headquartered in Houston, Texas. | Finance |
Ceros Pharmaceuticals, Inc.
Ceros Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ceros Pharmaceuticals, Inc. develops compounds to treat osteoporosis. The company is based in Houston, TX. The company was founded by Glenn Alfons Friedrich. Ceros Pharmaceuticals was acquired by Auxeris Therapeutics, Inc. on January 14, 2004. | Health Technology |
Progression Therapeutics, Inc.
Progression Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Progression Therapeutics, Inc. develops prognostic tests and therapies for the treatment of cancer. Its products are used in the treatment of primary and metastatic cancer. The firm develops a tumor suppressor gene product that has demonstrated potent anti-tumor activity both in vitro and in vivo. The company was founded on December 27, 2001 and is headquartered in Houston, TX. | Health Technology |
Kymab Ltd.
Kymab Ltd. Pharmaceuticals: MajorHealth Technology Kymab Ltd. discovers and develops human monoclonal antibody drugs. It is using mouse embryonic stem cell technology to develop its Kymouse platform that focuses on encompassing the diversity of the B lymphocyte component of the human immune system, and has the potential for expansion of diversity beyond the normal human immune response. Kymab was founded by Allan Bradley in 2009 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
Wrnch, Inc.
Wrnch, Inc. Packaged SoftwareTechnology Services Wrnch, Inc. operates as computer vision Software Company. It is an automated human motion capture system that takes 2D video and outputs 3D skeletonal animation data. The company was founded by Paul Kruszewski and is headquartered in Montreal, Canada. | Technology Services |
